Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("YUXIAN HE")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion : The Development of Novel Inhibitors for the Treatment of HIV InfectionYUXIAN HE.Current pharmaceutical design (Print). 2013, Vol 19, Num 10, pp 1800-1809, issn 1381-6128, 10 p.Article

Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulinsYUXIAN HE; D'AGOSTINO, Paul; PINTER, Abraham et al.Vaccine. 2003, Vol 21, Num 27-30, pp 4421-4429, issn 0264-410X, 9 p.Article

Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein : Implication for vaccine designYUXIAN HE; JINGJING LI; HECK, Susanne et al.Journal of virology. 2006, Vol 80, Num 12, pp 5757-5767, issn 0022-538X, 11 p.Article

Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirusYUXIAN HE; YUSEN ZHOU; SIDDIQUI, Pamela et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 8, pp 3718-3726, issn 0095-1137, 9 p.Article

Sublethal Effects of Imidacloprid on Bemisia tabaci (Hemiptera: Aleyrodidae) Under Laboratory ConditionsYUXIAN HE; JIANWEI ZHAO; DONGDONG WU et al.Journal of economic entomology. 2011, Vol 104, Num 3, pp 833-838, issn 0022-0493, 6 p.Article

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirusYUXIAN HE; YUSEN ZHOU; HAO WU et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 11, pp 5309-5314, issn 0095-1137, 6 p.Article

rOv-ASP-1, a recombinant secreted protein of the helminth onchocerca volvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigensMACDONALD, Angus J; LONG CAO; YUXIAN HE et al.Vaccine. 2005, Vol 23, Num 26, pp 3446-3452, issn 0264-410X, 7 p.Article

Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Thi-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccinesWENJUN XIAO; LANYING DU; CHAO LIANG et al.Vaccine. 2008, Vol 26, Num 39, pp 5022-5029, issn 0264-410X, 8 p.Article

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patientsLIFENG LIU; JING XIE; JIANPIN SUN et al.Scandinavian journal of infectious diseases. 2011, Vol 43, Num 6-7, pp 515-521, issn 0036-5548, 7 p.Article

Conserved Salt Bridge between the N-and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and InhibitionYUXIAN HE; SHUWEN LIU; JINGJING LI et al.Journal of virology. 2008, Vol 82, Num 22, pp 11129-11139, issn 0022-538X, 11 p.Article

Identification of a Critical Motif for the Human Immunodeficiency Virus Type 1 (HIV-1) gp41 Core Structure : Implications for Designing Novel Anti-HIV Fusion InhibitorsYUXIAN HE; JIANWEI CHENG; JINGJING LI et al.Journal of virology. 2008, Vol 82, Num 13, pp 6349-6358, issn 0022-538X, 10 p.Article

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infectionPINTER, Abraham; HONNEN, William J; YUXIAN HE et al.Journal of virology. 2004, Vol 78, Num 10, pp 5205-5215, issn 0022-538X, 11 p.Article

Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune ResponseGLOWACKA, Ilona; BERTRAM, Stephanie; NIEMEYER, Daniela et al.Journal of virology. 2011, Vol 85, Num 9, pp 4122-4134, issn 0022-538X, 13 p.Article

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapyLINQI ZHANG; RAMRATNAM, B; MARKOWITZ, M et al.The New England journal of medicine. 1999, Vol 340, Num 21, pp 1605-1613, issn 0028-4793Article

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvantGUANGYU ZHAO; LANYING DU; ZHENG, Bo-Jian et al.Vaccine. 2010, Vol 28, Num 44, pp 7233-7240, issn 0264-410X, 8 p.Article

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infectionLANYING DU; GUANGYU ZHAO; ZHENG, Bo-Jian et al.Vaccine. 2008, Vol 26, Num 13, pp 1644-1651, issn 0264-410X, 8 p.Article

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitorsSHUWEN LIU; GENGFU XIAO; SHIBO JIANG et al.Lancet (British edition). 2004, Vol 363, Num 9413, pp 938-947, issn 0140-6736, 10 p.Article

  • Page / 1